147 related articles for article (PubMed ID: 37323183)
1. Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9
Wang H; Chen F; Hu A; Liang H; Liang Y; Seetharamu N; Wang H; Dong J
Transl Lung Cancer Res; 2023 May; 12(5):1062-1077. PubMed ID: 37323183
[TBL] [Abstract][Full Text] [Related]
2. Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis.
Yu S; Bian H; Gao X; Gui L
Int J Mol Med; 2018 Apr; 41(4):2185-2192. PubMed ID: 29393380
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Annexin A9 Promotes Cell Proliferation and Migration in Gastric Cancer via the TGF-β Signaling Pathway.
Zhou Y; Qiu C; Wang T; Tao L; Zhang Z; Yao J
J Environ Pathol Toxicol Oncol; 2021; 40(3):87-94. PubMed ID: 34587407
[TBL] [Abstract][Full Text] [Related]
5. Exosome-derived ANXA9 functions as an oncogene in breast cancer.
Lu C; Zhan Y; Jiang Y; Liao J; Qiu Z
J Pathol Clin Res; 2023 Sep; 9(5):378-390. PubMed ID: 37294149
[TBL] [Abstract][Full Text] [Related]
6.
Miyoshi N; Yamamoto H; Mimori K; Yamashita S; Miyazaki S; Nakagawa S; Ishii H; Noura S; Ohue M; Yano M; Doki Y; Mori M
Oncol Lett; 2014 Nov; 8(5):2313-2317. PubMed ID: 25289111
[TBL] [Abstract][Full Text] [Related]
7. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of sulfotransferase 2B1 suppresses cell migration, invasion and promotes apoptosis in ovarian carcinoma cells via targeting annexin A9.
Gao H; Xia M; Ruan H
J Obstet Gynaecol Res; 2024 May; ():. PubMed ID: 38777329
[TBL] [Abstract][Full Text] [Related]
9. ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma.
Tang Y; Wang T; Zhang A; Zhu J; Zhou T; Zhou YL; Shi J
J Thorac Dis; 2023 Mar; 15(3):1018-1035. PubMed ID: 37065546
[TBL] [Abstract][Full Text] [Related]
10. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma.
Liu T; Zhu J; Du W; Ning W; Zhang Y; Zeng Y; Liu Z; Huang JA
Respir Res; 2020 Sep; 21(1):227. PubMed ID: 32873299
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
12. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
13. SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
Liu G; Li F; Chen M; Luo Y; Dai Y; Hou P
Front Genet; 2022; 13():813285. PubMed ID: 35356432
[No Abstract] [Full Text] [Related]
14. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
16. Enhanced Glioblastoma Selectivity of Harmine via the Albumin Carrier.
Liu SH; Wang QZ; Liu T; Bai R; Ma MM; Liu QL; Zhou HG; Liu J; Wang M
J Biomed Nanotechnol; 2022 Apr; 18(4):1052-1063. PubMed ID: 35854453
[TBL] [Abstract][Full Text] [Related]
17. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
18. LncRNA surfactant associated 1 activates large tumor suppressor kinase 1/Yes-associated protein pathway via modulating hypoxic exosome-delivered miR-4766-5p to inhibit lung adenocarcinoma metastasis.
Zhang W; Bai M; Liu K; Tan J; Ma J; Zhao J; Hou P
Int J Biochem Cell Biol; 2022 Dec; 153():106317. PubMed ID: 36283586
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
